Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great PR!
Smart!
It's tuff seeing the stock going up jg
And now it's going up.
That is what the stock market do :
Up and Down.
Right now I am not seeing that.
The chart looks like a staircase that goes up, up and up !!
FN
From equities:
http://www.equities.com/editors-desk/stocks/market-movers/nanoviricides-inc-nnvc-hits-new-52-week-low-during-april-22-session
Falling to a new 52-week low is never fun for company's shareholder, but, depending on who you ask, it can be either a buy or a sell signal. Someone bearish on the stock might see it reaching its lowest price in a year as a sign of growing downward momentum and make sure they sell their shares. Bulls, though, are more likely to see a new 52-week low as the stock hitting its low point and anticipate a bounce in the share price.
Today!
Make sense
Good for you!
Ah???????????
What so hilarious ?
So what are you going to say when you will realize that NNVC is not a BS company?
He disappeared like the way he showed up as a fictional cartoon character.
Or secret business ?
Way tooooo late!
Too late.
Agreed. That is a winner PR.
No prove no fact!
We will know around that time.
I said "Mid June should be it."
I didn't said "will be it"
You are saying " there will be no delivery to BASI by Mid June"
You can not prove what you affirm.
You cannot unswear my question.
That's not an unswear.
Explain with evidences why you are saying that there will be no delivery to BASI by mid June.
How do you know?
eugeneseymourmd@mac.com
Of course you would give me that unswear !
And ignoring all their success!
I understand.
Whatever.
I am sure that you cannot name 1 success.
Only because I love reading an amazing PR like this one:
Anti-Herpes Nanoviricides Reduce Extent of Disease and Mortality of HSV-1 Infected Animals
Published on April 21, 2015 at 6:13 AM
NanoViricides, Inc., (the "Company"), a nanomedicine company developing anti-viral drugs, reports dramatic improvement in clinical symptoms associated with herpes simplex virus infection in the recently completed studies in mice. The studies were performed in the laboratory of Dr. Ken S. Rosenthal at Northeast Ohio Medical University where Dr. Rosenthal is now Professor Emeritus. He is a leading researcher in herpes virus anti-viral agents and vaccines.
Two of the anti-Herpes nanoviricides® reduced the extent of disease (morbidity) and mortality of the HSV-1 infected animals that were treated. These nanoviricides also reduced virus production in cell culture. Importantly, topical dermal treatment with these nanoviricides led to almost complete (>85%) survival of the infected mice in this animal model whereas all untreated animals died of the disease. Further, these nanoviricides were superior to topical treatment with an acyclovir formulation employed as a positive control.
"Our broad-spectrum anti-herpes drug development program is now producing dramatic results in animal models," said Dr. Eugene Seymour, MD, MPH, CEO of the Company, adding, "Our drug candidates had previously exhibited greater than 99.9% viral load reduction in cell cultures. With the marked success in animal effectiveness, we believe that we will be able to declare a drug candidate against herpes viruses after certain additional testing."
The market size for herpes simplex virus treatments is in excess of $2 billion annually. The Company believes that a drug that is superior to existing therapies could result in significantly expanded market size.
The nanoviricides appeared to block the progression of the virus infection as observed by a reduction in the progression of the spreading of lesions.
Dr. Rosenthal suggested that "A delay in initiation of disease signs and the survival of the mice indicate a reduction of 90% or more in the production of virus possibly during the initial period of replication."
The nanoviricides prevented the development of scabbing of the herpes virus infected lesions in the animal model. For untreated and sham treated animals, the HSV infection progressed from initial redness at the site of infection to lesions that progressed on the skin along the nerve and internally to ultimately kill the mouse. Topical dermal treatment with these two nanoviricide formulations significantly delayed the onset of the clinical symptoms, prevented the progression of the lesions and produced survival of almost all of the mice (>85%).
Existing therapies against HSV include acyclovir and drugs chemically related to it. These drugs must be taken orally or by injection and are not very effective as topical agents. Other drugs are largely ineffective. Currently, there is no cure for herpes infection.
About Dr. Rosenthal
Dr. Rosenthal is Professor Emeritus at Northeast Ohio Medical University (NEOMED). He is a leading researcher in the field of herpes viruses, antiviral drugs and vaccines. His research interests encompass several aspects of how herpes simplex virus (HSV) interacts with the host to cause disease. His research has addressed how HSV infects skin cells and examined viral properties that facilitate its virulence and ability to cause encephalitis. He is also researching how the human host immune response works against HSV for the development of protective and therapeutic vaccines.
Source: http://www.nanoviricides.com/
Wow!
That is a PR!!
Great weedy
We will succeed! I Know it!
That is so not true.
Name 1 failure!
They are on the way to success.
Give it to early summer.
FN
Delivery to Basi
And other possibilities like a lot of buying.....
FN
Well he is right
It's a great opportunity to buy it at a low cost!
You should know that.
I am so happy to put a smile on your face! It's all good.
FN
Yes you are right
We never exaggerated because we have a great company
NNVC is BIG!
FN
We had already successful TOX with flucide the rest has to come
Mid June should be it.
FN
And of course the stock will be very high
I know when I am right
FN
Your last post was spot on KMBJN
Bravo
FN
You are right on time!
I meant joie de vivre
Thanks weedy
We need your Pom pom
And your Jolie de vivre
No doubt that NNVC is on his way to the moon.
Starting today.
FN